[HTML][HTML] Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Lipid nanoparticles (LNPs) have been one of the most successful nano-delivery vehicles
that enable efficient delivery of cytotoxic chemotherapy agents, antibiotics, and nucleic acid …
that enable efficient delivery of cytotoxic chemotherapy agents, antibiotics, and nucleic acid …
A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development
K Fowler, J Mucha, M Neumann, W Lewandowski… - BMC Public Health, 2022 - Springer
Background Cytomegalovirus (CMV) is a common pathogen that affects individuals of all
ages and establishes lifelong latency. Although CMV is typically asymptomatic in healthy …
ages and establishes lifelong latency. Although CMV is typically asymptomatic in healthy …
mRNA vaccines for COVID-19 and diverse diseases
Since its outbreak in late 2019, the novel coronavirus disease 2019 (COVID-19) has spread
to every continent on the planet. The global pandemic has affected human health and …
to every continent on the planet. The global pandemic has affected human health and …
40 years after the registration of acyclovir: do we need new anti-herpetic drugs?
A Majewska, B Mlynarczyk-Bonikowska - International journal of …, 2022 - mdpi.com
Herpes simplex virus types 1 and 2 HSV1 and 2, namely varicella-zoster VZV and
cytomegalovirus CMV, are among the most common pathogens worldwide. They remain in …
cytomegalovirus CMV, are among the most common pathogens worldwide. They remain in …
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
Background The optimal timing for SARS-CoV-2 vaccines within the first year after
allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods We conducted …
allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods We conducted …
Congenital cytomegalovirus and hearing loss: The state of the art
M Aldè, S Binda, V Primache, L Pellegrinelli… - Journal of Clinical …, 2023 - mdpi.com
In developed countries, congenital cytomegalovirus (cCMV) infection is the most common
congenital viral infection, representing the leading non-genetic cause of sensorineural …
congenital viral infection, representing the leading non-genetic cause of sensorineural …
Immune landscape of CMV infection in cancer patients: from “canonical” diseases toward virus-elicited oncomodulation
R El Baba, G Herbein - Frontiers in immunology, 2021 - frontiersin.org
Human Cytomegalovirus (HCMV) is an immensely pervasive herpesvirus, persistently
infecting high percentages of the world population. Despite the apparent robust host …
infecting high percentages of the world population. Despite the apparent robust host …
Lessons from acquired natural immunity and clinical trials to inform next-generation human cytomegalovirus vaccine development
Human cytomegalovirus (HCMV) infection, the most common cause of congenital disease
globally, affecting an estimated 1 million newborns annually, can result in lifelong sequelae …
globally, affecting an estimated 1 million newborns annually, can result in lifelong sequelae …
[HTML][HTML] Vaccine value profile for cytomegalovirus
Cytomegalovirus (CMV) is the most common infectious cause of congenital malformation
and a leading cause of developmental disabilities such as sensorineural hearing loss …
and a leading cause of developmental disabilities such as sensorineural hearing loss …
Congenital cytomegalovirus infection: the state of the art and future perspectives
S Salomè, FR Corrado, LL Mazzarelli… - Frontiers in …, 2023 - frontiersin.org
Congenital cytomegalovirus (cCMV) infection is the most common congenital infection, with
an estimated incidence of approximately one in 200 infants in high-income settings …
an estimated incidence of approximately one in 200 infants in high-income settings …